| Mutation of POC1B in a Severe Syndromic Retinal Ciliopathy BB Beck, JB Phillips, MP Bartram, J Wegner, M Thoenes, A Pannes, ... Human Mutation 35 (10), 1153-1162, 2014 | 70 | 2014 |
| Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression L O’Regan, J Sampson, MW Richards, A Knebel, D Roth, FE Hood, ... Journal of Cell Biology 209 (3), 349-358, 2015 | 56 | 2015 |
| Recent advances in pericentriolar material organization: ordered layers and scaffolding gels AM Fry, J Sampson, C Shak, S Shackleton F1000Research 6, 1622, 2017 | 55 | 2017 |
| Phase‐separated foci of EML4‐ALK facilitate signalling and depend upon an active kinase conformation J Sampson, MW Richards, J Choi, AM Fry, R Bayliss EMBO reports 22 (12), e53693, 2021 | 50 | 2021 |
| EML4‐ALK biology and drug resistance in non‐small cell lung cancer: a new phase of discoveries M Elshatlawy, J Sampson, K Clarke, R Bayliss Molecular Oncology 17 (6), 950-963, 2023 | 36 | 2023 |
| Hsp72 and Nek6 cooperate to cluster amplified centrosomes in cancer cells J Sampson, L O'Regan, MJS Dyer, R Bayliss, AM Fry Cancer Research 77 (18), 4785-4796, 2017 | 33 | 2017 |
| EML4-ALK variant 3 promotes mitotic errors and spindle assembly checkpoint deficiency leading to increased microtubule poison sensitivity K Lucken, L O'Regan, J Choi, J Sampson, SL Pashley, R Bayliss, S Khan, ... Molecular Cancer Research 20 (6), 854-866, 2022 | 15 | 2022 |
| Mitotic phosphorylation regulates Hsp72 spindle localization by uncoupling ATP binding from substrate release M Mukherjee, S Sabir, L O’Regan, J Sampson, MW Richards, ... Science signaling 11 (543), eaao2464, 2018 | 13 | 2018 |
| A polytherapy strategy using vincristine and ALK inhibitors to sensitise EML4-ALK-Positive NSCLC J Sampson, H Ju, J Song, AM Fry, R Bayliss, J Choi Cancers 14 (3), 779, 2022 | 8 | 2022 |
| Hsp70 proteins in mitosis and disease L O'Regan, J Sampson, AM Fry Oncotarget 6 (32), 32293, 2015 | 8 | 2015 |
| Phase-separation of EML4-ALK variant 3 is dependent upon an active ALK conformation J Sampson, MW Richards, J Choi, AM Fry, R Bayliss BioRxiv, 2020.06. 11.144485, 2020 | 2 | 2020 |
| HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors M Kim, H Ju, J Song, J Sampson, R Bayliss, J Choi Translational Lung Cancer Research 13 (2), 321, 2024 | 1 | 2024 |
| Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer J Sampson, H Ju, N Zhang, S Yeoh, J Choi, R Bayliss Cell Death & Disease 15 (12), 912, 2024 | | 2024 |
| ALKing the flames of lung cancer immunosensitivity R Bayliss, E Sarnowska, S Yeoh, J Sampson Molecular Oncology 17 (11), 2218-2220, 2023 | | 2023 |
| Recent advances in pericentriolar material organization: ordered layers and scaffolding gels [version 1; referees: 3 approved] AM Fry, J Sampson, C Shak, S Shackleton | | 2017 |
| Mitotic phosphorylation of Hsp72 uncouples ATP binding from substrate release and clusters amplified centrosomes in cancer cells. M Mukherjee, J Sampson, S Sabir, L O'Regan, MW Richards, ... Molecular Biology of the Cell 28 (26), T-361-T-362, 2017 | | 2017 |
Richard BaylissProfessor, University of LeedsZweryfikowany adres z leeds.ac.uk